Radha Karki

1.7k citations
27 papers · 1.4k indexed · h-index 21
Topics
Cancer therapeutics and mechanisms (19 papers)Bioactive Compounds and Antitumor Agents (15 papers)Synthesis and biological activity (15 papers)

In The Last Decade

Radha Karki

27 papers receiving 1.4k citations

Peers

Radha Karki
Comparison fields: 5 of 105
  • Organic Chemistry 859
  • Molecular Biology 725
  • Toxicology 276
  • Oncology 148
  • Materials Chemistry 94
Replace Haoqiang Lai with:
Haoqiang Lai China
Mariusz Mojzych Poland
William A. Kinney United States
Thomas A. Engler United States
Agnès Bombrun Switzerland
Marcin Cieślak Poland
Kumar Nikhil India
Clemens Zwergel Italy
Victor V. Tatarskiy Russia
Renukadevi Patil United States
Radha Karki relative to Haoqiang Lai China Haoqiang Lai's profile →
Citations per field
00.5×2.7×
Haoqiang Lai · 1×
Citations per year

Countries citing papers authored by Radha Karki

Since Specialization
Citations

This map shows the geographic impact of Radha Karki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radha Karki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radha Karki more than expected).

Fields of papers citing papers by Radha Karki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radha Karki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radha Karki. The network helps show where Radha Karki may publish in the future.

Co-authorship network of co-authors of Radha Karki

This figure shows the co-authorship network connecting the top 25 collaborators of Radha Karki. A scholar is included among the top collaborators of Radha Karki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radha Karki. Radha Karki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 38
2 22
3 39
4 97
5 33
6 24
7 30
8 10
9 196
10 58
11 68
12 21
13 49
14 82
15 10
16 38
17 62
18 46
19 115
20 2

About Radha Karki

Radha Karki is a scholar working on Toxicology, Organic Chemistry and Molecular Biology, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (19 papers), Bioactive Compounds and Antitumor Agents (15 papers) and Synthesis and biological activity (15 papers). The work is most often cited by research in Toxicology (276 citations), Organic Chemistry (859 citations) and Molecular Biology (725 citations). Radha Karki has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Younghwa Na, Youngjoo Kwon, Eung-Seok Lee, Eung-Seok Lee, Yurngdong Jahng, Bhaskar C. Das, Todd Evans, Peter J. Van Veldhuizen, Sasmita Das and Suman Kambhampati. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026